Emily E Hartwell
Overview
Explore the profile of Emily E Hartwell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davis C, Jinwala Z, Hatoum A, Toikumo S, Agrawal A, Rentsch C, et al.
JAMA Netw Open
. 2025 Jan;
8(1):e2453913.
PMID: 39786773
Importance: Recently, the US Food and Drug Administration gave premarketing approval to an algorithm based on its purported ability to identify individuals at genetic risk for opioid use disorder (OUD)....
2.
Jinwala Z, Green R, Khan Y, Gelernter J, Kember R, Hartwell E
medRxiv
. 2024 Nov;
PMID: 39606347
Background: Few individuals with alcohol use disorder (AUD) receive treatment. Previous studies have shown drinking behavior, psychological problems, and substance dependence to predict treatment seeking. However, to date, no studies...
3.
Clark S, Hartwell E, Choi D, Krystal J, Messing R, Ferguson L
Alcohol Clin Exp Res (Hoboken)
. 2024 Nov;
49(1):5-24.
PMID: 39532676
This critical review summarizes the current state of omics-based biomarkers in the alcohol research field. We first provide definitions and background information on alcohol and alcohol use disorder (AUD), biomarkers,...
4.
Hartwell E, Jinwala Z, Milone J, Ramirez S, Gelernter J, Kranzler H, et al.
Neuropsychopharmacology
. 2024 Jul;
49(13):1958-1967.
PMID: 39043921
Co-occurring psychiatric, medical, and substance use disorders (SUDs) are common, but the complex pathways leading to such comorbidities are poorly understood. A greater understanding of genetic influences on this phenomenon...
5.
Hartwell E, Schwandt M, Nunez Y, Wetherill R, Kember R, Wiers C, et al.
Am J Drug Alcohol Abuse
. 2024 Jul;
50(4):536-546.
PMID: 39018668
Substance use disorders (SUDs) are heterogeneous across multiple functional domains. Various frameworks posit that domains (e.g., executive function) contribute to the persistence of SUDs; however, the domains identified in different...
6.
Kranzler H, Davis C, Feinn R, Jinwala Z, Khan Y, Oikonomou A, et al.
Nat Hum Behav
. 2024 Jun;
8(8):1616-1627.
PMID: 38834750
Adverse childhood events (ACEs) contribute to the development of mood and anxiety disorders and substance dependence. However, the extent to which these effects are direct or indirect and whether genetic...
7.
Davis C, Jinwala Z, Hatoum A, Toikumo S, Agrawal A, Rentsch C, et al.
medRxiv
. 2024 May;
PMID: 38798430
Importance: Recently, the Food and Drug Administration gave pre-marketing approval to algorithm based on its purported ability to identify genetic risk for opioid use disorder. However, the clinical utility of...
8.
Khan Y, Davis C, Jinwala Z, Feuer K, Toikumo S, Hartwell E, et al.
medRxiv
. 2024 May;
PMID: 38766259
The etiology of substance use disorders (SUDs) and psychiatric disorders reflects a combination of both transdiagnostic (i.e., common) and disorder-level (i.e., independent) genetic risk factors. We applied genomic structural equation...
9.
Toikumo S, Vickers-Smith R, Jinwala Z, Xu H, Saini D, Hartwell E, et al.
Nat Med
. 2024 May;
30(7):2088.
PMID: 38714900
No abstract available.
10.
Toikumo S, Vickers-Smith R, Jinwala Z, Xu H, Saini D, Hartwell E, et al.
Nat Med
. 2024 Mar;
30(4):1075-1084.
PMID: 38429522
Chronic pain is a common problem, with more than one-fifth of adult Americans reporting pain daily or on most days. It adversely affects the quality of life and imposes substantial...